StageZero Life Sciences Ltd (SZLS) — Strategic Asset Allocation Index

Latest as of September 2022: 38.8%

StageZero Life Sciences Ltd (SZLS) has a Strategic Asset Allocation Index of 38.8% as of September 2022. Strategic assets (PP&E of CA$560.20K plus long-term investments of CA$-) total CA$560.20K, measured against net assets of CA$1.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See StageZero Life Sciences Ltd (SZLS) net asset quality to measure how much of total assets are equity-financed.

SAAI

38.8%

Strategic Assets / Net Assets

Strategic Assets

CA$560.20K

PP&E + LT Investments

PP&E

CA$560.20K

CAD

Net Assets

CA$1.44 Million

CAD

StageZero Life Sciences Ltd Strategic Asset Allocation Index (2021–2021)

This chart shows how StageZero Life Sciences Ltd's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 38.8%, representing strategic assets of CA$560.20K against net assets of CA$1.44 Million CAD. For live market cap and overall valuation, see StageZero Life Sciences Ltd (SZLS) total market value.

Annual Strategic Asset Allocation Index for StageZero Life Sciences Ltd (2021–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for StageZero Life Sciences Ltd from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See StageZero Life Sciences Ltd book value and equity for net asset value and shareholders' equity analysis.

Year	SAAI	Strategic Assets (CAD)	PP&E	LT Investments	Net Assets	Change (pp)
2021	31.6%	CA$871.89K	CA$871.89K	CA$-	CA$2.76 Million	—

pp = percentage points